Want to receive the latest Esophageal Cancer news delivered to your inbox?
Use the form below to never miss an important update from the medical community about Esophageal Cancer, new studies and developments.
Bariatric Surgery may increase Risk of Precursor of Esophageal Cancer
Study finds bariatric surgery known as sleeve gastrectomy increases the risk of Barrett’s Esophagus, the [...]
Sleep Habits Affect Risk of Esophageal Cancer
Study finds Sleep Habits affect Risk of Esophageal Cancer. Researchers at Washington University School [...]
Campaign for Esophageal Cancer Research Funding
Over the past two years, more than $11 million in new federal funding has been [...]
Preventing Chemo Brain? Study Identifies Potential Approach for Common Problem
A side effect of some cancer treatments commonly referred to as “chemo brain” has received [...]
Groundbreaking Study on How Barrett’s Esophagus becomes Cancer
A new study from Great Britain underscores the importance of early detection of Barrett's Esophagus [...]
Three New Immunotherapy Indications for Esophageal Cancer Patients
Since March 2021, the U.S. Food and Drug Administration has issued four approvals for PD-L1 [...]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies [...]
New Treatment Option for Patients with HER2+ Gastroesophageal Junction Adenocarcinoma
The U.S. Food & Drug Administration has approved a new therapy for adult patients with [...]
Latest US Stats Show More Esophageal Cancer Cases, Fewer Deaths
The latest statistics released by the American Cancer Society projects that fewer Americans will die [...]
Groundbreaking Immunotherapy Studies in Esophageal Cancer show Significant Benefits
Findings of three studies important to Esophageal Cancer patients were presented at the 2020 ESMO [...]
Personalized Approach Shows Survival Benefit in Esophageal Adenocarcinoma
Results of a clinical study called PANGEA (Personalized ANtibodies for GastroEsophageal Adenocarcinoma) found survival benefits [...]
Immunotherapy Breakthroughs for Esophageal Cancer Patients
The early results of two large, Phase III clinical trials of the immunotherapy Opdivo (nivolumab) [...]